CapitalOne Starts Olema Pharmaceuticals (OLMA) at Overweight

May 5, 2023 6:08 AM EDT Send to a Friend
CapitalOne analyst Zegbeh Jallah initiates coverage on Olema Pharmaceuticals (NASDAQ: OLMA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login